4-(5-phenyl-1,3,4-oxadiazol-2-yl)pyridine
Structure Info
- Chemspace ID
- CSSB00103430351 (In-Stock Building Blocks)
- CAS
- 56353-00-5
- MFCD
- MFCD00228315
- IUPAC Name
- 4-(5-phenyl-1,3,4-oxadiazol-2-yl)pyridine
- Mol formula
- C13H9N3O
- Mol weight
- 223 Da
- Catalog Number(s)
- 5137518, 7119520728, AA017VLQ, AGN-PC-0JVLR2, AR017WDI, AU47066, CSC103430351, CSCR00007257972, CUS50324252, D080-0030, DP01996, EBC-611754, EC017XUA, F0777-1733, IBS-E0415787, JH344818, LN00774332, OSSK_625188, ST017X5A, STK866392, STOCK6S-68493, TX017WU6, Z50148375, a6_2355_60948, s_271570_9487570_21749824, s_271570____9487570____21749824
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- 1.79
- Heavy atoms count
- 17
- Rotatable bond count
- 2
- Number of rings
- 3
- Carbon bond saturation, Fsp3
- 0
- Polar surface area (Å)
- 52
- Hydrogen bond acceptors count
- 3
- Hydrogen bond donors count
- 0
- Zoom the structure
- CSSB00103430351
Items Overall 5 items from 2 suppliers
| Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
|---|---|---|---|---|---|---|
| AA Blocks CN | 12 days | China To: | 90 | 1 mg | 107.80 | |
| AA Blocks CN | 12 days | China To: | 90 | 5 mg | 150.70 | |
Description: 4-(5-phenyl-1,3,4-oxadiazol-2-yl)pyridine; CAS: 56353-00-5 | ||||||
| Accel Scientific, S.L. | 20 days | China To: | 95 | 100 mg | 584.10 | |
| Accel Scientific, S.L. | 20 days | China To: | 95 | 250 mg | 768.90 | |
| Accel Scientific, S.L. | 20 days | China To: | 95 | 1 g | 1,505.90 | |
Description: 4-(5-phenyl-1,3,4-oxadiazol-2-yl)pyridine; CAS: 56353-00-5 | ||||||
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire
![Chemical structure of 2-[5-(pyridin-4-yl)-1,3,4-oxadiazol-2-yl]aniline - CSSB00015184238](/st/structure/200/c510d3d792be560f94c608151f01985a/NC1%253DCC%253DCC%253DC1C1%253DNN%253DC%2528O1%2529C1%253DCC%253DNC%253DC1.png)
![Chemical structure of 4-methyl-2-[5-(pyridin-4-yl)-1,3,4-oxadiazol-2-yl]aniline - CSSB00015184775](/st/structure/200/1e1f26ed144cc199eb5a015dc1fb4b62/CC1%253DCC%253DC%2528N%2529C%2528%253DC1%2529C1%253DNN%253DC%2528O1%2529C1%253DCC%253DNC%253DC1.png)
![Chemical structure of 4-fluoro-2-[5-(pyridin-4-yl)-1,3,4-oxadiazol-2-yl]aniline - CSSB00015187295](/st/structure/200/4c6099129308235094e1125d45397af8/NC1%253DCC%253DC%2528F%2529C%253DC1C1%253DNN%253DC%2528O1%2529C1%253DCC%253DNC%253DC1.png)
![Chemical structure of 4-{5-[4-(trifluoromethyl)phenyl]-1,3,4-oxadiazol-2-yl}pyridine - CSSB00104232019](/st/structure/200/f36c8f033222f2bb465a3577d2ca8ff3/FC%2528F%2529%2528F%2529C1%253DCC%253DC%2528C%253DC1%2529C1%253DNN%253DC%2528O1%2529C1%253DCC%253DNC%253DC1.png)

![Chemical structure of 4-[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]-2-phenylquinoline - CSSB00026601848](/st/structure/200/3ebc838234d71bd26ba4b3093aaf28ca/CC1%253DCC%253DC%2528C%253DC1%2529C1%253DNN%253DC%2528O1%2529C1%253DCC%2528%253DNC2%253DCC%253DCC%253DC12%2529C1%253DCC%253DCC%253DC1.png)
![Chemical structure of 4-[5-(pyridin-4-yl)-1,3,4-oxadiazol-2-yl]pyridine - CSSB00102587592](/st/structure/200/d41bd65523b496b09c25381c19716223/O1C%2528%253DNN%253DC1C1%253DCC%253DNC%253DC1%2529C1%253DCC%253DNC%253DC1.png)





